Inhibikase Therapeutics Inc
NASDAQ:IKT
Inhibikase Therapeutics Inc
NASDAQ:IKT
Price:
1.58
USD
-5.95%
Market Closed
Market Cap:
$191.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Inhibikase Therapeutics Inc
NASDAQ:IKT
|
US |
|
Reading International Inc
NASDAQ:RDI
|
US |
|
Superdry PLC
LSE:SDRY
|
UK |
|
Gerard Perrier Industrie SA
PAR:PERR
|
FR |
|
C
|
Chemical Industries (Far East) Ltd
SGX:C05
|
SG |
|
AMA Group Ltd
ASX:AMA
|
AU |
|
U
|
Unit Corp
OTC:UNTC
|
US |
|
AC Energy Corp
OTC:ACPIF
|
PH |
|
Mach7 Technologies Ltd
ASX:M7T
|
AU |
|
Semen Indonesia (Persero) Tbk PT
OTC:PSGTY
|
ID |
|
Turk Prysmian Kablo ve Sistemleri AS
IST:PRKAB.E
|
TR |
|
K
|
KMF Builders and Developers Ltd
BSE:531578
|
IN |
Wall Street
Price Targets
IKT Price Targets Summary
Inhibikase Therapeutics Inc
Inhibikase Therapeutics Inc
Wall Street analysts forecast IKT stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
IKT
is 5.87 USD
with a low forecast of 3.03 USD and a high forecast of 8.4 USD.
Lowest
Price Target
3.03
USD
92% Upside
Average
Price Target
5.87
USD
271% Upside
Highest
Price Target
8.4
USD
432% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is IKT's stock price target?
Price Target
5.87
USD
5.87
USD
According to Wall Street analysts, the average 1-year price target for
IKT
is 5.87 USD
with a low forecast of 3.03 USD and a high forecast of 8.4 USD.
